All posts by imreal

American Life Settlements Awarded Registered Trademark after 20 Years in Business


Continued growth is forecast. The population of potential applicants increases by the day. The number of people in America age 65 or above is estimated to grow to 82 million by 2040 and 98 million by 2060.

We are proud to announce that our Life Settlement Brokerage, American Life Settlements®, received its Registered Trademark on December 10, 2019. July 10, 2000, was confirmed as our service mark’s first use in commerce, making us among the oldest Life Settlement Brokerages. The U.S. Patent and Trademark Office categorized our company as providing “Financial services, namely, insurance policy brokerage, settlement, and loan services.” Many exclusive and enforceable rights were conferred to us as a result.

American Life Settlements: What we do.

American Life Settlements is a family-owned Life Settlement Brokerage based in Carmel, Indiana. During our 20 years in business, we have helped people from ages 32 to 93 with lifespans up to 23 more years or less than 5 sell their life policies. Life Settlement Brokers owe a fiduciary duty to policy owners. This requires orchestrating competition among a great many Life and Viatical Settlement Providers, including TV advertisers. Each Provider utilizes doctors, actuaries, and life insurance underwriters. Larger cases may require Providers to buy Lifespan Estimate Reports. All these efforts require comprehensive medical records of active conditions that may impact longevity. This process ultimately reveals each policy’s true market value, which is not possible with a calculator or quick quote by phone without any hard facts. American Life Settlements®, with decades in the business and a nationwide network of buyers, is unequaled in both industry expertise and dedicated customer care. The event of our Registered Trademark validates our many years of hard work delivering great results for our clients.

Current Business Climate: Continued growth is forecast.

Here are the facts: The population of potential applicants increases by the day. The number of people in America age 65 or above is estimated to grow from 52 million (2018) to 82 million by 2040 and 98 million by 2060.

Average Life Settlement payouts range from 4 to 8 times the cash surrender value. Most people do not know that Convertible Term policies are the easiest to sell for top dollar. Yet only $3.8 billion of Life Settlements were transacted in 2018 while some $200 billion of life insurance was terminated without quotes.

Why are seniors leaving a fortune on the table? The primary reason is that there are not enough licensed professionals advising clients about Life Settlements.

Our Company’s Difference: American Life Settlements helps licensed professionals to transact Life Settlements.

Licensed professionals may add Life Settlements to their practice in a compliant and appropriate manner. These include, but are not limited to, life insurance agents, securities representatives, investment advisers, financial and estate planners, accountants of every variety, and attorneys. Those who cannot accept Life Settlement compensation may have it added to client payouts. Being able to advise about Life Settlements is of particular importance to those who already owe a fiduciary duty to their clients.

American Life Settlements does not sell products or financial advice. Clients are free to use or invest their money as they choose. Thus, we do not compete with Advisors who associate with us.

Company History: Making the transition from selling life insurance to brokering Life Settlements.

Our life insurance agency of 1987 began transacting Life Settlements in 1998. One of our first clients was our President and Founder’s close friend of many years, a retired Marine Colonel from the Korean Conflict who started up a business after retiring from his corporate VP position. His Life Settlement of our Convertible Term policy saved his home from foreclosure and enabled him to rebuild his savings. Bringing cash to the living was far more rewarding than delivering death claims. With encouragement from him, his wife, and other happy clients, Morris Heins founded American Life Settlements before launching his first Website in 2000.

More Information:

Website: https://americanlifesettlements.com

Licensed Professionals: https://americanlifesettlements.com/company/

LinkedIn: https://www.linkedin.com/in/morris-heins/

Phone: 888-247-3659

Share article on social media or email:

California State Treasurer and Thirty Percent Coalition Renew Effort to Advance Women to Corporate Board Seats


News Image

California’s gender diversity law is helping to achieve this goal, but it appears help is still needed in bringing women and corporations together. That’s where our new effort with the Coalition is focused.

California State Treasurer Fiona Ma has teamed up with the Thirty Percent Coalition in a new effort to accelerate the number of women named to public company boards in California. While the state was the first to mandate gender diversity in boardrooms, progress has been slow.

A law signed by Gov. Edmund G. Brown, Jr. on September 20, 2018 required public companies with principal executive offices in California to meet certain requirements by the end of 2019. The law mandated two female directors if a company has five directors on its board and three if it planned to have seven female directors by the close of 2021. One analysis of California Publicly Traded Corporate Disclosure Statements filed in 2019 suggests that fewer than half of companies affected may be meeting these requirements. [1]

“I have always been a strong champion of advancing women in the workplace and ensuring that we hold a representative share of leadership positions in business,” Treasurer Ma said. “California’s gender diversity law is helping to achieve this goal, but it appears help is still needed in bringing women and corporations together. That’s where our new effort with the Coalition is focused.”

“We are honored to welcome the California Treasurer’s Office as a member of the Thirty Percent Coalition. There are exciting new initiatives on the horizon that we believe can help accelerate gender diversification on corporate boards and keep us all on track,” said Charlotte Laurent-Ottomane, Thirty Percent Coalition Executive Director.

As companies continue to seek to diversify their boards, the Coalition and the Treasurer’s Office are poised to help their efforts succeed. In August and September two webinars hosted by Treasurer Ma and Charlotte Laurent-Ottomane are planned to help more women make the transition to serving on corporate boards and assist companies in achieving their diversity objective. Details will be released closer to the dates of the webinars.

The first webinar will provide Tips on How to Land a Board Seat for women wishing to become candidates for board positions in California. Speakers will include members of the National Association of Women Business Owners (NAWBO) and Women in Public Finance (WPF).

A second webinar for CEOs, Diversity—The Road to a Performing Board, will recognize that diversifying a board can be a complex undertaking. Guidance and insight will be provided on how to approach board diversity while considering markets, governance, and optimal board composition.

Treasurer Ma has established a database of women interested in serving on corporate boards in California. To be included in the Treasurer’s Women on Board Registry List, interested women are encouraged to send a resume via email to WomensRegistry@Treasurer.Ca.Gov. Public companies interested in participating in this effort may also submit the company’s name and a point of contact to the same address.

About the California State Treasurer

Fiona Ma is California’s 34th State Treasurer. She was elected on November 6, 2018 with more votes (7,825,587) than any other candidate for treasurer in the state’s history. She is the first woman of color and the first woman Certified Public Accountant (CPA) elected to the position. The State Treasurer’s Office was created in the California Constitution in 1849. It provides financing for schools, roads, housing, recycling and waste management, hospitals, public facilities, and other crucial infrastructure projects that better the lives of residents. California is the world’s fifth-largest economy and Treasurer Ma is the state’s primary banker. Her office processes more than $2 trillion in transactions within a typical year. She provides transparency and oversight for the government’s investment portfolio and accounts, as well as for the state’s surplus funds. Treasurer Ma oversees an investment portfolio of about $99 billion, more than $31.4 billion of which are local government funds. She serves as agent of sale for all State bonds, and is trustee on outstanding debt of $94 billion.

About the Thirty Percent Coalition

Founded in 2011, the Thirty Percent Coalition is a pioneer in promoting diversity in the corporate boardroom. The mission is to advocate for gender diversity, including women of color, on public and private boards. The Coalition provides a national forum where its members develop strategies to influence companies to increase gender diversity in senior leadership and boardrooms. Membership includes public companies, private equity, institutional investors, state treasurers, professional services firms and advocacy groups working together for the first time. In 2020, Coalition members represent over $6 trillion in assets under management. There is no other organization of this kind in the US.

Media Contacts:

Charlotte Laurent-Ottomane, Executive Director, Thirty Percent Coalition. Email: CLO@30percentcoalition.org, Tel. (209) 505 3690

Mark DeSio, Communications Director, California State Treasurer’s Office. Email: Mark.DeSio@treasurer.ca.gov, Tel. (916) 651-6088

1. Harvard Law School Forum on Corporate Governance on 3/18/2020: As required by SB 826, California’s board gender diversity law, the California Secretary of State has posted its March 2020 report on the status of compliance with the new law. The report combines information gathered in the July 2019 report with data for the additional six-month period of July 1, 2019 through December 31, 2019. The report counts 625 publicly held corporations that identified principal executive offices in California in their 2019 10-Ks, but indicates that only 330 of these “impacted corporations” had filed a 2019 California Publicly Traded Corporate Disclosure Statement, which would reflect their compliance with the board gender diversity requirement. Of the 330 companies that had filed, 282 reported that they were in compliance with the board gender diversity mandate.

Share article on social media or email:

Navigating the New Normal in Pharmaceutical Commercialization, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

This webinar will cover the actions that pharmaceutical commercial teams can take now to stay on track with 2020 goals and to plan for 2021.

COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in-line and launch brands to meet the new reality of customer and business needs during the ongoing pandemic.

This webinar will cover the actions that pharmaceutical commercial teams can take now to stay on track with 2020 goals and to plan for 2021. Pharmaceutical and biotech commercialization teams will hear about trends in the marketplace during the last few months of marketing, medical affairs, market access strategy and customer communication during COVID-19. We will discuss the choices teams have made and the rationale for different approaches. Whether you are seeking to re-start pharmaceutical commercialization or planning for a new launch, the short and long-term planning guidance discussed will be of value.

Join Brent Herspiegel, President of Herspiegel Consulting and Brian Torres, Principal at Herspiegel Consulting in a live webinar on Wednesday, July 22, 2020 at 1pm EDT (6pm BST/UK).

For more information or to register for this event, visit COVID-19: Navigating the New Normal in Pharmaceutical Commercialization.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

NFP Ventures Makes Strategic Investment in Kindbody, a Provider of a Fertility and Family-Building Benefit Solution


News Image

“NFP remains focused on specialized benefit solutions that address the evolving needs of employers and their employees,” said Shawn Ellis, managing director of NFP Ventures.

NFP Ventures, the early-stage investment arm of NFP, today announced a strategic investment in Kindbody, the innovative provider of a fertility and family-building solution. The investment, NFP Ventures’ first in a company both founded and fully led by women, includes plans to offer Kindbody’s services to NFP clients so they can integrate the services into employee benefit plan programs.

Kindbody offers end-to-end fertility and family-building services, serving as both a provider and a network solution. Their offering covers fertility treatments, gynecology and LGBTQ+ services, as well as mental health counseling and wellness coaching, to provide one solution from preconception through postpartum. Their approach features direct purchasing and inclusive bundled rates, which allows Kindbody to offer pricing that is up to 30% less than other fertility platforms. NFP clients will have access to Kindbody’s full suite of fertility, wellness, and family-building offerings.

“NFP remains focused on specialized benefit solutions that address the evolving needs of employers and their employees,” said Shawn Ellis, managing director of NFP Ventures. “Kindbody provides affordable fertility services with an exceptional client experience, and is driven by the passion and vision of a stellar female leadership team. We’re excited to partner with them to expand access to family planning assistance.”

“Cost and experience become increasingly important in challenging times and Kindbody’s unique solution addresses these factors directly,” said Mike Goldman, president and chief operating officer of NFP. “We will continue to work with our clients to understand their needs and connect them with innovative solutions – like Kindbody – that help employees overcome a variety of significant challenges.”

“We are thrilled about this investment from NFP Ventures and our plans to maximize the benefits of our partnership for all stakeholders,” said Kindbody cofounder and CEO Gina Bartasi. “NFP’s focus on providing solutions that clients value, creates a path for Kindbody to expand the impact of family planning services and expertise.”

About Kindbody

Kindbody provides fertility, gynecology, and family-building services in modern, tech-enabled clinics and virtually. They are both a provider and a network solution, offering superior results at significantly lower prices, and a reimagined member experience.

About NFP

NFP is a leading insurance broker and consultant providing specialized property and casualty, corporate benefits, retirement and individual solutions through its licensed subsidiaries and affiliates. NFP enables client success through the expertise of over 5,600 global employees, investments in innovative technologies, and enduring relationships with highly rated insurers, vendors, and financial institutions. NFP is the 5th largest benefits broker by global revenue, 6th largest US-based privately owned broker, and 8th best place to work in insurance (Business Insurance); 10th largest property and casualty agency (Insurance Journal); and 13th largest global insurance broker (Best’s Review).

Visit NFP.com to discover how NFP empowers clients to meet their goals.

About NFP Ventures

NFP Venture, LLC (NFP Ventures) is a venture fund launched by NFP that focuses on strategic partnerships and investments in the emerging Insurtech, Fintech and HR Tech arenas. NFP Ventures’ mission is to find, fund and work successfully with visionary executives, providing them with expertise to foster long-term success. Typically, NFP Ventures targets companies seeking Seed to Series B investment that can benefit from NFP’s distribution, human capital and other unique assets to accelerate their growth.

Share article on social media or email:

New Safety Measures Implemented at Eastman Periodontics and Implants’ Bradenton and Lakewood Ranch, FL Locations Amid COVID-19 Pandemic


Drs. Christie Eastman-Craighead, Lindsay Eastman, and Justin Craighead, Periodontists in Bradenton, FL

Drs. Christie Eastman-Craighead, Lindsay Eastman, and Justin Craighead, Periodontists in Bradenton, FL

With decades of experience as gum disease specialists, the clinicians at Eastman Periodontics and Implants have seen first-hand how this disease can have a negative effect on not only oral health but systemic health as well.

Eastman Periodontics and Implants announce their new safety measures amid the COVID-19 pandemic. Founder Dr. Lindsay Eastman, along with his associates, Drs. Christie Eastman-Craighead and Justin Craighead, welcome existing and new patients in the Sarasota, Bradenton, and Lakewood Ranch areas to receive high-quality and trusted dental care in comfort. As skilled periodontists, they also warn their community of the harmful effects untreated dental conditions like gum disease can have on overall health, and advise patients to seek treatment as soon as symptoms arise.

Persistent bad breath, sensitive teeth, and bleeding, swollen, or receding gums are all common signs of gum disease. According to the Centers for Disease Control and Prevention (CDC) nearly 50 percent of adult Americans have some form of gum disease. With decades of experience as gum disease specialists, the clinicians at Eastman Periodontics and Implants have seen first-hand how this disease can have a negative effect on not only oral health but systemic health as well.

Gum disease is caused by an infection of the gums. If left untreated, disease-causing bacteria have been shown to spread throughout the body leading to chronic inflammation, a strained immune system, and systemic conditions including cardiovascular disease.

In order to protect their patients and community’s health, they encourage those showing signs of gum disease, and any other dental concerns, to receive the care they need before the condition worsens. Striving to not only offer a comfortable environment for patients but one that limits the spread of the novel coronavirus, Eastman Periodontics and Implants has implemented additional safety guidelines since they reopened. These safety measures include the following:


  • Staff members will wear personal protection equipment (PPE) at all times when with patients
  • Virtual treatment discussions are available to reduce the number of in-office visits
  • Patients call before arriving, limiting the number of visitors in the reception area
  • A/C units have received upgrades including air scrubbers to improve air quality
  • Air purification systems by Air Oasis® with PECOS technology are active throughout the office
  • Cutting-edge aerosol reduction systems are used including the Purevac® HVE System and Ivory® ReLeaf™
  • Patient rooms are disinfected before and after each visit using EPA-approved chemicals

Eastman Periodontics and Implants has been serving Bradenton, Lakewood Ranch, and surrounding communities for over 35 years. Offering high-quality and honest care has always been an essential part of their practice. During the COVID-19 pandemic, they strive to be a guiding light to those with oral concerns as well as those in need of treatment from an office they can trust. They will continue to monitor updates made by the CDC, American Dental Association (ADA), World Health Organization (WHO) as well as local and federal authorities and modify their safety measures accordingly.

To schedule a gum disease consultation or to learn more about the new steps Eastman Periodontics and Implants have taken to limit the spread of COVID-19, call their Bradenton practice at 941-792-3899 or their Lakewood Ranch location at 941-351-3000. To read more about this skilled team of periodontists with over 55 years of combined experience, visit http://www.eastmanonline.com.

About the Periodontists

Eastman Periodontics and Implants was founded by Dr. Lindsay Eastman in 1980. Now with two locations in Bradenton and Lakewood Ranch, FL, Dr. Eastman also has two associates, his daughter Dr. Christie Eastman-Craighead and his son-in-law Dr. Justin Craighead. Dr. Eastman is a respected authority in periodontology with experience implementing revolutionary techniques and developing ones of his own, he continually sets and surpasses the bar for periodontal care. A skilled and published periodontist, Dr. Eastman-Craighead received her Doctorate of Dental Medicine Degree and her Professional Certificate in Periodontics from the University of Florida. Dr. Craighead is both a periodontist and a prosthodontist, a feat rarely accomplished by clinicians across the country. The team at Eastman Periodontics and Implants blend the latest, minimally invasive technology with an honest approach to care. To learn more about these doctors, the services they offer, or their cutting-edge practice, visit http://www.eastmanonline.com or call 941-792-3899 for the Bradenton location or 941-351-3000 for the Lakewood Ranch location for a personalized consultation.

Share article on social media or email:

Nvoicepay Announces Josh Cyphers as President of Nvoicepay


…I am excited to step into this new role as we continue to expand capabilities and partnerships to provide services and solutions for finance teams.

Nvoicepay, a FLEETCOR company, is announcing Josh Cyphers as the company’s new President. Formerly the Vice President of Product and Strategy for Nvoicepay, Cyphers takes over from Co-Founder and CEO Karla Friede, who is departing after eleven years to devote her time to continued work as an angel investor and board member.

The leadership announcement comes on the heels of Nvoicepay’s new strategic partnership with Beanworks to offer an enhanced payments platform for the US market, helping businesses operate with a completely digital payment workflow for remote payment approvals and payment processes.

“As the global economy transitions into remote work environments and a challenging economic climate, Nvoicepay is uniquely positioned to streamline the accounts payable process for businesses across various verticals and industries, empower remote teams and significantly reduce back office costs,” said Josh Cyphers, President of Nvoicepay, a FLEETCOR Company. “I am excited to step into this new role as we continue to expand capabilities and partnerships to provide services and solutions for finance teams.”

Prior to his role as VP of Nvoicepay, Cyphers has managed successful growth for a variety of companies, from start-ups to Fortune 100 companies. He has served in leadership roles at Microsoft, Nike, and several fast-growing enterprise software companies. Josh is a former CPA and has a BS in Economics from Eastern Oregon University.

“We are thrilled to have Josh in this role. He not only brings a deep understanding of the marketplace and a clear vision for the future, but also has the broad support of the Nvoicepay team, which has enthusiastically embraced him as their new leader,” said John Coughlin, Group President of Corporate Payments of FLEETCOR.

About Nvoicepay:

Nvoicepay, a FLEETCOR company, transforms the way firms pay their domestic and international suppliers. For over 500 customers across 2,700 entities, the company optimizes electronic invoice payments for enterprises with intuitive cloud-based software and comprehensive services. Only Nvoicepay offers an intelligence-driven payment automation solution purpose-built for the most complex firms. By automating all payments, finance teams win through dynamic supplier activation, superior supplier services, and remarkable results, unlocking value in the payments process. Visit https://www.nvoicepay.com/ or contact Nvoicepay to learn more.

Share article on social media or email:

Largent Health Announces FDA Clearance for FiteBac® Antimicrobial Cavity Cleanser


News Image

With the introduction of FiteBac® Antimicrobial Cavity Cleanser, we can now offer dentists a differentiated product to both help the dental professional ensure the restoration site is clear of carious debris and assist in addressing residual microbial contamination within the restoration site.

Largent Health, LLC announced today a new FDA clearance to market the novel FiteBac® Antimicrobial Cavity Cleanser, with 2% K21. Dental cavity cleansers are used for cleansing and moistening/re-wetting of prepared dental surfaces prior to completion of tooth restoration. The company included in their FDA application, compelling data supporting antimicrobial activity that reduces dentally relevant microbes.

FiteBac® technology exemplifies the marriage of antimicrobial technology to material science, enabling the manufacture of modern materials offering sustained, non-leaching antimicrobial protection across a broad range of products. “The FDA clearance of FiteBac® Antimicrobial Cavity Cleanser represents the 2nd successful FDA regulatory clearance of our FiteBac® technology this year,” said John W. Sharkey, Ph.D., CEO of Largent Health, LLC. “This further validates our unique FiteBac® technology and its potential in the development of additional medical products with durable antimicrobial technology built-in.”

FiteBac® Antimicrobial Cavity Cleanser, with 2% K21, is intended to become part of the restoration/dentin interface by copolymerizing with the dental adhesive. Research shows FiteBac® Cavity Cleanser can not only help remove debris in carious lesion preparations but also help reduce the presence of dentally relevant organisms within the prepared tooth structure and to penetrate exposed dentin tubules, allowing restorative adhesives to tightly bind to the prepared dentin surface.

“With receipt of FDA clearance in hand, we look forward to implementing production scale-up and pre-launch activities over the coming weeks,” said Jude Dinges, Chief Commercial Officer at Largent Health. “With the introduction of FiteBac® Antimicrobial Cavity Cleanser, we can now offer dentists a differentiated product to both help the dental professional ensure the restoration site is clear of carious debris and assist in addressing residual microbial contamination within the restoration site.”

To learn more about how FiteBac® technology is being developed for medical applications please visit http://www.LargentHealth.com

About Largent Health LLC

Largent Health, LLC, based in Marietta, GA, is a private company dedicated to the research, development and commercialization of innovative healthcare products incorporating FiteBac® technology, a superior approach to antimicrobial protection. To learn more please visit http://www.LargentHealth.com.

Share article on social media or email:

The American Diabetes Association Advises Careful Management of Blood Sugar Levels For Diabetics During Pandemic


Delicious Strawberry or Orange Flavored Glucose Gels

Available in natural Orange or Strawberry flavors, these 15-gram packets supply a delicious gel alternative to sugar cubes or candy bars for the fastest energy absorption

The elderly and people with underlying medical conditions such as cardiovascular disease, chronic respiratory disease, chronic kidney disease, obesity, organ transplant patients, cancer and diabetes are at a higher risk of getting severe Covid-19 disease. For diabetics, managing blood sugar is especially important to stay on top of their disease and at peak fitness during times when their immune systems must function at a higher level.

Nothing works better at bringing blood-sugar levels up fast than Transcend Glucose Gels to help with that management. Glucose gels are fast-acting fuel that revitalize and correct blood sugars when they fall due to insulin use. They come in natural Orange or Strawberry flavors in 15-gram packets and supply a delicious gel alternative to sugar cubes or candy bars for the fastest energy absorption. Plus, they are easy to pack and carry with you when you travel. Even athletes with no diabetes are discovering the benefits of fast-acting Transcend Glucose Gels.

The American Diabetes Association states, “When people with diabetes do not manage their diabetes well and experience fluctuating blood sugars, they are generally at risk for a number of diabetes-related complications.” They go on to say that if people with diabetes do not manage their diabetes well and experience fluctuating blood sugars, they face a higher chance of experiencing serious complications from Covid-19.

Find Transcend Glucose Gels in various quantity packs at reduced prices at FirstAidGlobal.com

Share article on social media or email:

SPH Analytics Announces Dedicated Solution for California’s Integrated Healthcare Association Commercial HMO AMP Program


News Image

In order to ensure the measure accuracy needed to support quality reporting, IHA recently made the decision that provider organizations who elect to self-report to IHA must partner with a vendor who uses a certified measure engine to calculate the quality measures.

SPH Analytics, a leader in healthcare quality and experience analytics, today announced that it has expanded its top-rated population health solution to support California-based Integrated Healthcare Association’s (IHA’s) Commercial HMO Align. Measure. Perform. (AMP) program. IHA’s Commercial HMO AMP program was originally launched in 2001, and has grown into one of the largest value-based performance benchmarking programs in the country. The program participants include eleven health plans and more than 200 California physician organizations caring for over 9 million Californians enrolled in commercial HMO and point of service products—representing 95% of commercial HMO enrollment in the state.

With this product expansion, provider organizations can now use the SPH Analytics solution to participate as a self-reporting provider organization in the Commercial HMO AMP program. SPH’s solution integrates directly into a provider’s electronic medical record system to automate the extraction and normalization of clinical data, which is then used to calculate and monitor quality performance according to IHA’s specific list of AMP quality measures. SPH Analytics turnkey solution also supports Auditor and IHA submission, whereby performance is measured, and incentives are calculated with top performers recognized across regional and state-wide efforts.

“The AMP program has been an industry leader for many years,” said Kevin Weinstein, President, Population Health at SPH Analytics. “In order to ensure the measure accuracy needed to support quality reporting, IHA recently made the decision that provider organizations who elect to self-report to IHA must partner with a vendor who uses a certified measure engine to calculate the quality measures. We are thrilled to bring such a solution to our California-based providers, empowering them to measure and improve quality performance in an ongoing and cost-effective manner.”

Provider organizations now have the option to contract directly with a vendor using an NCQA-certified engine and self-report their results to IHA. The advantages of self-reporting are:


  • Continuous performance monitoring across all measures throughout the year prior to end of year submission;
  • Guaranteed compliance for submission of quality measure data to IHA
  • Audit assistance throughout the year to ensure compliance and optimal performance
  • Additional quality measures from other quality programs (HEDIS®, MIPS, ACO, Medicaid, and commercial payers) can be tracked within the same dashboard
  • Supplemental clinical data exports to individual health plans that promote payer and provider collaboration can be easily generated and shared

With SPH Analytics’ portfolio of top-ranked population health solutions and robust library of measures, provider organizations can utilize one award-winning partner to optimize participation in multiple value-based quality programs, including IHA’s Commercial HMO AMP program, MIPS/MACRA, HEDIS, state Medicaid and other commercial payer-sponsored programs.

To learn more about SPH’s new solution for the IHA’s Commercial HMO AMP program, visit resources.sphanalytics.com/amp.

About SPH Analytics

SPH Analytics (SPH), a leader in healthcare analytics and population health management, empowers clients to analyze and interpret their clinical, financial, and consumer experience data to maximize their performance. SPH’s Population Care™, Population Value™, and Population Engage™ solutions are built on the innovative Nexus™ Platform, providing insights and impact to integrated health networks, ACOs, hospitals, ambulatory care providers, physician groups, and health plans. SPH’s quality measure dashboards, financial risk measurement, healthcare survey and patient outreach solutions, and consulting services empower clients to meet the Triple Aim by improving population health, reducing overall cost of care, and improving the patient experience.

SPH Analytics is headquartered in metro Atlanta and has provided insights to clients for more than 35 years, serving clients in all 50 states. For more information, call 1-866-460-5681 or visit SPHAnalytics.com.

Share article on social media or email:

Palette Life Sciences Launches The PedSpace, a New Podcast Series Created For and Presented By Healthcare Professionals


News Image

As a pediatric urologist, I’m delighted to be participating in this new series developed specifically by and for my peers and I hope they will find it a valuable and interesting new resource.” – Dr. Aaron Martin, Board-certified Pediatric Urologist of Children’s Hospital New Orleans

Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced the launch of a new podcast series, The PedSpace, created specifically for and presented by pediatric urology healthcare professionals. The podcast series is a featured resource in Palette’s new Deflux Learning Center, an online platform that provides information, education and training globally for pediatric urologists and their peers who treat vesicoureteral reflux (VUR) and other pediatric urology conditions. VUR, sometimes referred to as urinary or bladder reflux, is a serious pediatric urinary condition in which urine flows from the bladder through one or both ureters toward the kidneys.

The PedSpace podcast series features physicians discussing the field of pediatric urology, compelling VUR-related information, Deflux as a treatment option, broader topics such as telemedicine and more. In the first episode, “The Art of a Telemedicine Visit,” Dr. Aaron Martin, Board-certified Pediatric Urologist at Children’s Hospital New Orleans discusses best practices for virtual patient care. In the second episode, “Telemedicine and VUR,” Dr. Martin discusses telemedicine in the context of VUR. In the third episode, “Improving the VUR Grading System,” Dr. Christopher Cooper, Board-Certified Pediatric Urologist at Stead Family Children’s Hospital in Iowa, discusses the limitations of the current VUR grading system, asserting that not all VUR is created equal, and asking if the old method of grading is obsolete.

“As a pediatric urologist, I’m delighted to be participating in this new series developed specifically by and for my peers, and I hope they will find it a valuable and interesting new resource,” said Dr. Aaron Martin, Board-certified Pediatric Urologist of Children’s Hospital New Orleans.

“Palette Life Sciences is dedicated to supporting learning and collaboration among pediatric urologists. Through the launch of The PedSpace podcast series and our Deflux Learning Center, we hope to play an important role in improving patient outcomes,” said Rich Low, head of marketing, Palette Life Sciences. “These are just two examples of how we are making significant new investments in physician education and training, fostering peer-to-peer collaboration for the ultimate benefit of our young patients and their caregivers.”

In addition to The PedSpace podcast series, the Deflux Learning Center contains comprehensive VUR and Deflux-related information, education, training, tools and resources to support healthcare professionals who treat VUR. The PedSpace can also be subscribed to via Apple, Google, or Spotify podcasts.

About Deflux

Deflux is a minimally invasive, outpatient treatment that has been proven safe and effective in children with vesicoureteral reflux (VUR). VUR is a serious pediatric urinary condition in which urine refluxes from the bladder through one or both ureters toward the kidneys, due to an abnormality at the junction of the ureter and the bladder. Deflux is an injectable gel bulking agent made from two tissue-friendly polysaccharides; Non-Animal Stabilized Hyaluronic Acid (NASHA®) and dextranomer (Dx) microspheres. The product is administered via injection around the ureteral opening to prevent urine reflux. Deflux is indicated in the United States for children with VUR grades II-IV, and is indicated outside of the United States for all grades of VUR. For more information, visit https://deflux.com.

About Palette Life Sciences AB

Palette Life Sciences is a fully integrated life sciences company. Palette Life Sciences’ products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Deflux®, Solesta® and Barrigel®. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life. Led by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California, and Dallas, Texas. Learn more at https://www.palettelifesciences.com.

Share article on social media or email: